Study of symptoms and quality of life for women with genitourinary syndrome of menopause
Part of Kidney & urinary, Mental health, Women’s health & pregnancy clinical trials.
This study looks at medical records of women with genitourinary syndrome of menopause (GSM) – a condition causing vaginal dryness, irritation, or urinary issues after menopause – who were treated with a product called XCM INTIM. The goal is to see how their symptoms and quality of life changed after at least 8 weeks of treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has gone through menopause (no period for at least 12 months)
- You have at least one symptom of genitourinary syndrome of menopause (like vaginal dryness, burning, or urinary problems) that affected your quality of life
- You were treated with XCM INTIM and had a check-up at least 8 weeks after starting treatment
- You were seen at the Hospital Universitario La Luz in Madrid between January 2022 and April 2026
- You did not use any vaginal hormone products 4 weeks before starting XCM INTIM, or systemic estrogen therapy 8 weeks before
- You did not have other gynecological or urinary conditions (like active infections, pelvic organ prolapse stage III or higher, or severe stress incontinence) that could confuse the results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new non-hormonal gel for vaginal dryness and discomfort after menopause. It aims to see if the gel improves quality of life.
This trial tests a treatment for menopause-like vaginal symptoms that can happen after breast cancer treatment. It aims to help survivors feel more comfortable.
This trial tests a non-invasive radiofrequency treatment to relieve vaginal dryness, irritation, and other symptoms caused by menopause. It may be a good option if you are postmenopausal and sexually active.
This trial tests a non-surgical radiofrequency treatment, combined with pelvic floor exercises, to help with vaginal dryness and other menopause symptoms in breast cancer survivors. It may be an option if you are free of cancer and have bothersome vaginal dryness.
This study examines vaginal dryness and discomfort—common side effects of breast cancer treatment—in women who've survived the disease. Researchers want to understand how often this happens and how much it affects daily life, which may help doctors better support survivors.
This trial tests a Chinese herbal formula called TJAOA103 for women with moderate-to-severe menopause symptoms like vaginal dryness, itching, or pain during sex. It aims to see if the herbs can help without hormones.
Hear when a new Vulvar Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.